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Existing estimates of the incidence of infectious intestinal disease (IID) caused by norovirus are based on
electron microscopy or reverse transcription-polymerase chain reaction (RT-PCR). Neither method accurately
represents norovirus disease burden: Electron microscopy has poor diagnostic sensitivity, and RT-PCR has poor
diagnostic speciﬁcity. In this study, viral load measurements were used to identify cases of norovirus-associated
IID and to produce new incidence estimates for England. IID cases were ascertained in the Study of Infectious
Intestinal Disease in England (1993–1996), and stool specimens were tested by semiquantitative real-time RT-
PCR for norovirus. The age-adjusted community incidence of norovirus-associated IID was 4.5/100 person-years
(95% credibility interval: 3.8, 5.2), equating to 2 million episodes/year. Among children aged less than 5 years, the
community incidence was 21.4/100 person-years (95% credibility interval: 15.9, 27.7), and the incidence of con-
sultations to general practitioners for norovirus-associated IID was 3.2/100 person-years (95% credibility interval:
2.6, 3.8), with 100,000 children visiting their general practitioner for norovirus-associated IID each year. Norovirus
is the most common cause of IID in the community in England and is responsible for a similar number of pediatric
primary care consultations as rotavirus.
England; gastroenteritis; incidence; Monte Carlo method; Norovirus; primary health care; reverse transcriptase
polymerase chain reaction
Abbreviations: IID, infectious intestinal disease; ROC, receiver operating characteristic; RT-PCR, reverse transcription-polymer-
ase chain reaction.
Norovirus is the most common cause of infectious intes-
tinal disease (IID) in the community in high-income coun-
tries (1–4), and a substantial prevalence of norovirus
infection has been reported among IID cases seeking med-
ical care (5). Existing estimates of norovirus-associated IID
incidence in the community and among individuals present-
ing to their general practitioner in England are based on
electron microscopy, which has poor diagnostic sensitivity
for identifying norovirus-associated IID (6–8); it is very
likely that these estimates underrepresent the burden of
norovirus disease.
Reverse transcription-polymerase chain reaction (RT-
PCR) is now the preferred diagnostic method for norovirus.
However, semiquantitative real-time RT-PCR testing has
demonstrated a wide range of viral loads in norovirus-
infected IID cases (8); many IID cases shed norovirus at
the same concentration as healthy individuals, with no re-
cent history of IID (8, 9). It is therefore unlikely that all IID
cases with norovirus infection detected by RT-PCR have
disease caused by norovirus; another pathogen is probably
causing illness in IID cases shedding norovirus at very low
concentrations. Only individuals with IID caused by noro-
virus should be included in estimates of norovirus disease
burden.
We demonstrated in previous work that viral load mea-
surements can be used to identify IID cases with disease
caused by norovirus and to exclude IID cases with ‘‘asymp-
tomatic’’ norovirus infection concurrent with disease caused
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by another pathogen (8). In this study, we used viral load
measurements from IID cases in the Study of Infectious
Intestinal Disease in England to improve estimates of
the incidence of norovirus-associated IID in the community
and leading to general practice consultations. Accurate es-
timates of norovirus-associated IID incidence at the commu-
nity level are essential for understanding the introduction of
norovirus into health-care settings, where outbreaks cause
substantial economic burden and service disruption (10),
and for informing potential vaccination programs (11, 12).
MATERIALS AND METHODS
Recruitment and all-cause IID incidence
Data are taken from the Study of Infectious Intestinal
Disease in England (‘‘the IID Study’’), conducted between
1993 and 1996 (13). The incidence of IID in the community,
caused by any pathogen, was estimated in a prospective co-
hort, which was demographically representative of the pop-
ulation of England. Cohort members were actively followed
up, with weekly null reporting, to ensure that all IID epi-
sodes were recorded (14).
The incidence of general practitioner consultations for
IID, caused by any pathogen, was estimated by recruiting
individuals with IID presenting to one of the 70 participating
general practices (14). Incidence numerators were adjusted
for underascertainment of IID cases, and denominators were
adjusted for registered patients no longer using the practices
(4, 14).
IID cases were individuals with diarrhea (any loose
stools) or significant vomiting (2 vomiting episodes/24
hours), lasting less than 2 weeks, without a known nonin-
fectious cause, preceded by a symptom-free period of at
least 3 weeks (14). Healthy controls, with no recent history
of IID, were recruited concurrently to cases in both study
components, from the community cohort or from the gen-
eral practice patient registration lists (13). Informed
consent was obtained from all participants at the time of
recruitment.
Specimens and testing
IID cases provided a fecal specimen during acute illness,
and controls provided a specimen at recruitment. Norovirus
was detected by electron microscopy, and specimens were
archived in frozen storage (15). All specimens, including
those previously positive by electron microscopy, were
later retested for norovirus using a more sensitive RT-PCR
assay. All norovirus RT-PCR-positive specimens were re-
tested by using a semiquantitative RT-PCR assay (run for
40 cycles) (16). Recruitment and stool testing in IID cases
are summarized in Table 1.
The cycle threshold value from the real-time RT-PCR
assay provides a proxy measure of fecal viral load; it is
inversely proportional to the amount of virus present in
the specimen. The distribution of norovirus cycle threshold
values in IID cases and controls used in this study has been
described previously (8).
Calculating norovirus incidence
The incidence of norovirus-associated IID (INV) was
calculated as follows:
INV ¼ I3 pðNVÞ3A; ð1Þ
where I is the incidence of all-cause IID/100 person-years,
p(NV) is the proportion of IID cases positive for norovirus
by RT-PCR, and A is a factor used to adjust for those IID
cases with norovirus infection at low viral loads who there-
fore do not have disease caused by norovirus.
In a previous analysis of norovirus cycle threshold values
from the IID Study, we used receiver operating characteris-
tic (ROC) analysis to select a cutoff for attributing disease to
norovirus in IID cases (8). However, standard ROC analysis
does not provide confidence limits around the selected cut-
off. In this analysis, the cycle threshold value distributions
from the reference groups in the ROC analysis were used to
calculate adjustment factor A, incorporating uncertainty in
these distributions due to sampling error into the incidence
estimate. The reference-positive group included IID cases
with norovirus detected by electron microscopy, because
they have viral loads representative of where norovirus in-
fection is causing disease (17, 18). The reference-negative
group included healthy controls, because they have viral
loads representative of where norovirus infection is not
causing any illness.
Adjustment factor A was calculated as follows:
A ¼
Xi¼39
i¼15
Cti3
RPi
RPi þ RNi; ð2Þ
where RPi is the moving average of the proportion of the
Table 1. Summary of Case Recruitment and Stool Specimen
Testing in the Community Cohort and General Practice Component
of the Study of Infectious Intestinal Disease, England, 1993–1996
Community
Cohort
General
Practice
Study
Base population,
person-years of follow-up
4,026 409,878a
Ascertained cases, no. 781 13,619b
Stool specimens, no. 761 2,893c
Electron microscopy
positive for norovirus, no.
50 169
Stool specimen archived, no. 517 1,905
RT-PCR positive for
norovirus, no.d
211 623
Cycle threshold value
determined with real-
time RT-PCR, no.
174 544
Abbreviation: RT-PCR, reverse transcription-polymerase chain re-
action.
a Adjusted for registered patients no longer actively using partici-
pating general practices.
b Adjusted for underascertainment.
c Stool specimens were collected from patients in only 34 of the 70
general practices recruiting cases.
d Includes those previously positive by electron microscopy.
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reference-positive group at cycle threshold (Ct) value i (over
i  2 to i þ 2); RNi is the moving average of the proportion
of the reference-negative group at cycle threshold value i
(over i  2 to i þ 2); and Cti is the proportion of IID cases
positive by real-time RT-PCR with cycle threshold value i.
Adjustment factor A varies between 0 and 1. Adjustment
factor A is a weighted average of the relative frequency of
the reference-positive and reference-negative groups at each
cycle threshold value, weighted by the proportion of all
norovirus-infected IID cases at each cycle threshold value
(Figure 1).
Figure 2 shows the distribution of cycle threshold values
in the reference groups and the value of the subcomponent
(RPi/(RPi þ RNi)), which represents the relative frequency
of the reference groups. At low-cycle threshold values,
where viral loads are high and there are few individuals
from the reference-negative group, the subcomponent
(RPi/(RPi þ RNi)) is close to 1, indicating that the majority
of IID cases with norovirus infection at these concentra-
tions have disease caused by norovirus. In contrast,
at the high-cycle threshold values (low viral loads) found
in the majority of the disease-free reference-negative
group, the subcomponent (RPi/(RPi þ RNi)) is close to
0, indicating that very few IID cases with norovirus
infection at these concentrations have disease caused by
norovirus.
Adjustment factor A was calculated separately for chil-
dren aged less than 5 years and for older children and adults
(aged 5 years or older) in the age-stratified and age-adjusted
incidence.
Incidence estimation by Monte Carlo simulation in
WinBUGS
The incidence of norovirus-associated IID was calculated
by using Monte Carlo simulation in WinBUGS, version 1.4,
software (19). Confidence limits for norovirus-associated
IID incidence are provided as Bayesian credibility intervals
from the posterior sampling distribution. The all-cause IID
incidence/100 person-years (I) from the IID Study was mod-
eled by using a log-normal distribution. Proportions were
modeled by using binomial distributions with noninforma-
tive uniform priors. Multinomial distributions were used to
model the cycle threshold value distributions, with nonin-
formative Dirichlet prior distributions. The simulation was
run for 300,000 iterations, from 3 different sets of initial
values, to check convergence.
Separate simulations were run to estimate the incidence
of norovirus in the community and the incidence of general
practice consultations and to calculate age- and season-strat-
ified incidence. The numbers of IID cases with norovirus
cycle threshold values limited the number of age groups in
which the community incidence could be presented. Age-
adjusted incidence was calculated as a weighted average of
the incidence in children aged less than 5 years and in older
children and adults (aged 5 years or older); weights were taken
from the mid-1994 population estimate for England, obtained
from the Office of National Statistics, United Kingdom. The
annual numbers of cases of norovirus-associated IID were
calculated from the incidence estimates and the age-stratified
mid-1994 population estimate for England.
Figure 1. Distribution of norovirus cycle threshold values in IID cases from the Study of Infectious Intestinal Disease, England, 1993–1996. Black
bars are IID cases from the community cohort (n¼ 174); white bars are IID cases from the general practitioner study (n¼ 544). Ct, cycle threshold;
IID, infectious intestinal disease.
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Alternative methods for estimating the proportion of IID
cases with disease attributable to norovirus
We used 3 further methods to estimate the proportion of
IID cases with disease attributable to norovirus, which either
do not require a control group or have been used in previous
studies.
Alternative method 1. In previous studies using only RT-
PCR, not semiquantitative real-time RT-PCR, the proportion
of norovirus-infected IID cases with disease attributable to
norovirus has been estimated as the difference in norovirus
prevalence between the control group and IID cases (5). We
calculated norovirus-associated IID incidence as follows:
INV ¼ I3 pðNVÞcase  pðNVÞcontrol

; ð3Þ
where p(NV)case represents the norovirus prevalence among
IID cases, and p(NV)control represents the norovirus preva-
lence among controls.
Alternative method 2. We have previously defined a cut-
off in norovirus genogroup II cycle threshold values for
attributing disease to norovirus (8). We applied this cutoff
(at cycle threshold value 30 for children aged <5 years and
at cycle threshold value 33 for older children and adults) to
IID cases with a cycle threshold value for either norovirus
genogroup I or genogroup II. The proportion of IID cases
with a norovirus cycle threshold value at or below the cycle
threshold value cutoff was substituted for adjustment factor
A in equation 1. To explore the effect of late specimen
collection on norovirus incidence, we defined probable
cases of norovirus-associated IID as those IID cases with
a cycle threshold value above the cutoff, a specimen col-
lected 5 or more days after symptom onset, and no other
pathogen detected. These probable cases were added to the
IID cases with a norovirus cycle threshold value at or below
the cutoff.
Alternative method 3. We used mixture modeling to es-
timate the proportion of IID cases with a norovirus cycle
threshold value that have disease attributable to norovirus,
using only data from IID cases. This proportion was
substituted for adjustment factor A in equation 1 and un-
certainty represented by using a beta distribution, based on
the confidence interval provided from the mixture model.
Details of the mixture model are provided in the Web
Appendix (http://aje.oxfordjournals.org/).
We also estimated the incidence of norovirus-associated
IID based on electron microscopy testing using equation 3:
INV ¼ I3P; ð4Þ
where P is the proportion of cases positive by electron mi-
croscopy. The incidence of norovirus-associated IID based
on classifying any norovirus RT-PCR-positive IID case as
a case of norovirus-associated IID and the incidence of
rotavirus-associated IID based on enzyme-linked immuno-
sorbent assay diagnosis (20) (in children aged <5 years
only) were calculated in the same way.
RESULTS
The crude community incidence of norovirus-associated
IID was 4.1/100 person-years (Table 2); after age
Figure 2. Distribution of norovirus cycle threshold values in reference-positive and reference-negative groups, selected from participants in the
Study of Infectious Intestinal Disease, England, 1993–1996, and adjustment factor subcomponent RP i /(RPiþ RN i ). Black bars are the reference-
positive group (n ¼ 119); white bars are the reference-negative group (n ¼ 199); triangle symbols show the adjustment factor subcomponent RPi /
(RPi þ RN i ). RPi , moving average of the proportion of the reference-positive group at cycle threshold value i ; RNi , moving average of the
proportion of the reference-negative group at cycle threshold value i.
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adjustment, the community incidence was 4.5 episodes/100
person-years (Table 2). Incidence was highest in children
aged less than 5 years, with 20% experiencing norovirus-
associated IID every year. Community norovirus–associated
IID incidence peaked between October and March (Table 2).
There were 0.5 general practice consultations for
norovirus-associated IID/100 person-years (Table 2). The
incidence of general practice consultations was highest
among children aged less than 2 years, at 6.4/100 person-
years. Approximately 1 of 7 children aged less than 5 years
with norovirus-associated IID consulted a general practi-
tioner, compared with 1 of 3 of those with rotavirus-
associated IID in this study population (Table 2). The
seasonality of general practice consultations for norovirus-
associated IID was less pronounced than in the community
(Table 2).
Incidence based on the cycle threshold value cutoff was
slightly lower than using adjustment factor A, and the cred-
ibility intervals were narrower, as shown in Table 3 and the
Web table (http://aje.oxfordjournals.org/). Subtracting the
control norovirus prevalence from that in IID cases pro-
duced higher incidence estimates in young children, but
lower estimates in older children and adults. Mixture
modeling produced the lowest estimates.
DISCUSSION
This is the first study to use viral load measurements to
estimate the incidence of norovirus-associated IID. A recent
volunteer study showed that low norovirus viral loads, de-
tectable by RT-PCR, are associated with asymptomatic
infection (9). Consideration of viral load therefore provides
the greatest diagnostic accuracy for identifying cases of
norovirus-associated IID. Using such an approach, we have
demonstrated that norovirus is the most common cause of
IID, across all age groups, in the community in England (4),
and that there is a substantial incidence of general practice
consultations for norovirus-associated IID among young
children (Table 4), similar to that caused by rotavirus.
Estimates of norovirus disease burden based on viral load
are very likely to be more accurate than those based on
electron microscopy, because electron microscopy has poor
diagnostic sensitivity, or those based on RT-PCR, because it
is possible to exclude IID cases who are RT-PCR positive
Table 2. Incidence of Norovirus-associated Infectious Intestinal Disease in England, 1993–
1996a
Community
General Practice
Consultation
Ratio of
Community to
General
Practice
Cases
Incidence/
100 Person-
Years
95%
Credibility
Interval
Incidence/
100 Person-
Years
95%
Credibility
Interval
Crude 4.1 3.4, 4.8 0.49 0.43, 0.55 8.4
Age adjusted 4.5 3.8, 5.2 0.54 0.48, 0.60 8.3
Age stratiﬁed
<5 years 21.4 15.9, 27.7 3.2 2.6, 3.8 6.7
5 years 3.3 2.6, 3.9 0.35 0.30, 0.39 9.7
0–1 year 27.2 17.9, 38.6 6.4 5.2, 7.7 4.3
2–4 years 16.7 11.4, 23.3 1.5 1.2, 2.0 11.1
5–14 years 6.5 4.5, 8.9 0.44 0.31, 0.59 14.8
15–44 years 4.1 3.1, 5.3 0.38 0.32, 0.45 10.8
45 years 1.7 1.1, 2.3 0.29 0.24, 0.35 5.9
45–64 years 0.26 0.20, 0.32
65 years 0.37 0.27, 0.47
Season stratiﬁed
January–March 4.7 3.4, 6.3 0.46 0.37, 0.57
April–June 3.8 2.7, 5.1 0.52 0.43, 0.62
July–September 3.3 2.4, 4.5 0.43 0.35, 0.51
October–December 4.8 3.6, 6.3 0.56 0.46, 0.66
Rotavirus-associated IID
0–1 year 13.7 5.6, 25.1 6.4 5.2, 7.7 2.1
2–4 years 6.2 2.5, 11.5 1.5 1.2, 2.0 4.1
5 years 8.5 4.6, 13.6 3.2 2.6, 3.8 2.7
Abbreviation: IID, infectious intestinal disease.
a The incidence of rotavirus-associated infectious intestinal disease is shown also for children
aged less than 5 years.
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but have low viral loads and are therefore unlikely to have
disease caused by norovirus. We developed a method for
calculating norovirus-associated IID incidence that allowed
statistical uncertainty in the viral load measurements to be
incorporated into the confidence limits. This was only pos-
sible with the use of Monte Carlo simulation methods to
combine the multiple components of the calculation and
their associated statistical uncertainty; this would have been
extremely difficult using standard frequentist approaches,
such as the Delta Method, because of the large number of
variables in the calculation. Although the estimates pre-
sented here are based on data collected between 1993 and
1996, they provide the best available information on the
burden of norovirus disease in England. Furthermore, these
results are based on current diagnostic methods; as new
studies are carried out, they will provide a baseline from
which to assess changes in norovirus incidence over time
that are not confounded by concurrent changes in the sen-
sitivity of diagnostic methods.
There was limited resolution for estimating age-stratified
incidence in the community because of the small sample
size. We combined genogroup I and genogroup II norovirus
infections in this analysis, rather than estimating adjustment
factor A separately for each genogroup, also because of
limited sample size. Similarly, in alternative method 2, we
used a cycle threshold value cutoff developed for genogroup
II specimens only, because no published cutoff exists for
genogroup I. There is evidence that the real-time RT-PCR
assay has lower efficiency for genogroup I norovirus strains
(Jim Gray, Health Protection Agency Centre for Infections,
personal communication, 2009), so that a given cycle
threshold value may represent a higher viral load in the
original stool specimen for some genogroup I strains, com-
pared with genogroup II strains. Genogroup I noroviruses
constituted less than 10% of the norovirus isolates in the
study, so we believe that grouping the genogroups would
result in conservative incidence estimates, rather than
overestimation.
The concentration of norovirus excretion decreases sub-
stantially after symptom resolution (9). Although we made
no direct adjustment for the possibility that some IID cases
with high cycle threshold values may have had disease
caused by norovirus, but had low viral loads at the time
of specimen collection because their symptoms had al-
ready resolved, the method used to calculate adjustment
factor A does allow some IID cases with high norovirus
cycle threshold values to be incorporated into the incidence
estimate (Figure 2). It therefore indirectly allows for the
possibility that some IID cases who truly had norovirus-
associated IID had low viral loads at the time of testing. It
is not possible to directly allow for late specimen collec-
tion using adjustment factor A, because it is calculated at
the population level. Direct consideration of delay in spec-
imen collection requires classification of norovirus disease
status at the individual level, as was done when applying
the cycle threshold value cutoff (alternative method 2). We
recalculated the cutoff-based incidence of norovirus-asso-
ciated IID, including probable cases (defined as having
a high cycle threshold value, a late specimen, and no other
detected pathogens) and found that the incidence wasTa
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slightly higher than using only the cases below the cycle
threshold value cutoff, but still very similar to those ob-
tained using adjustment factor A. However, we would urge
caution in using such an approach, because the number of
probable cases will be highly dependent on assay sensitiv-
ity and on the number of cycles for which the real-time RT-
PCR assay is run; not all IID cases with norovirus detected
and a late specimen may have actually had disease caused
by norovirus.
The method we used is dependent on the recruitment and
testing of a large control group, which are not always pos-
sible. We used a number of alternative methods to adjust the
prevalence of norovirus in IID cases, to explore whether
these produce suitably similar results to our method, which
we believe to be most robust. As expected, using the cycle
threshold value cutoff produced slightly lower incidence
estimates with narrower credibility intervals, because the
uncertainty in the cutoff was not represented in the calcula-
tions. We found that mixture modeling gave similar results
to the cycle threshold value cutoff, although there was
a tendency toward underestimation; mixture modeling also
requires larger sample sizes than the other methods, prevent-
ing estimation of detailed age-stratified incidence estimates.
Estimates produced by subtracting the prevalence of noro-
virus in controls from that in IID cases were very different
from those produced using the other methods; incidence in
young children was substantially overestimated, and inci-
dence in older children and adults was underestimated. Fur-
thermore, estimates produced with this method will be
highly dependent on the case definition used, the source of
the controls, and the study setting.
The new estimates of norovirus-associated IID inci-
dence presented here are approximately 3 times higher in
the community and 2.5 times higher at the general practi-
tioner level than previous estimates for England based on
electron microscopy (4). Accordingly, the ratio of commu-
nity cases to cases presenting to general practitioners in-
creased from 6 to 1, using electron microscopy diagnosis,
to 8 to 1, using viral load measurements (4). The incidence
estimates are approximately half those obtained by assum-
ing that any IID cases with a positive RT-PCR result for
norovirus has disease caused by norovirus, indicating that
without consideration of viral load there is the potential for
substantial overestimation of the burden of norovirus
disease.
The community incidence estimates are comparable to
those from a study in the Netherlands, which used RT-
PCR testing to identify cases of norovirus-associated IID
but had a narrower case definition for IID (3 or more loose
stools, or 2 or more episodes of vomiting in 24 hours), which
may not have been sensitive enough to ascertain all episodes
of norovirus-associated IID at the community level (1). Sim-
ilarly, the incidence of general practitioner consultations for
norovirus was only slightly lower than that from a recent
study in Germany, which used RT-PCR diagnosis for nor-
ovirus, but again this study had a narrower case definition
for IID (2 or more loose stools, or 2 or more vomiting
episodes in 24 hours) (21). The incidence of norovirus-as-
sociated IID may also have been higher than normal during
our study because a new variant of norovirus emerged dur-
ing 1995 and 1996 (22–24); emergence of norovirus variants
has been associated with increased disease incidence (25–
28).
The incidence of norovirus-associated IID in the commu-
nity showed a slight peak in the winter and autumn months,
while general practice consultations were reasonably con-
stant throughout the year. Outbreaks of norovirus-associated
IID in community settings in the United Kingdom show
very little seasonality, in strong contrast to outbreaks in
health-care settings, which show marked winter-time sea-
sonality (29). A number of factors may contribute to these
differing patterns of seasonality between community dis-
ease and outbreaks in different settings. First, community
norovirus outbreaks are more commonly reported from ca-
tering settings, with transmission occurring through food
contamination; while the prevalence of norovirus infection
among food handlers is likely determined by the incidence
of community disease, the driving factor in these outbreaks
is breakdown in food hygiene practices, which is not a sea-
sonal phenomenon. Second, it has been suggested that the
Table 4. Estimated Annual Numbers of Norovirus-associated Infectious Intestinal Disease
Cases in the Community and Consulting a General Practitioner in England, 1993–1996
Age Group
Community General Practice Consultation
Thousands
of Cases
95%
Credibility
Interval
Thousands
of Cases
95%
Credibility
Interval
Age adjusted 2,175.8 1,836.8, 2,543.0 261.5 233.4, 290.6
0–1 year 81.0 65.4, 97.8
2–4 years 30.4 22.7, 38.8
<5 years 691.4 513.4, 897.1 103.7 85.2, 123.2
5–14 years 403.1 279.0, 550.3 27.1 18.9, 36.6
15–44 years 854.3 635.6, 1,104.9 78.6 65.1, 93.0
45 years 308.4 211.4, 426.8 54.9 45.0, 65.6
45–64 years 28.2 21.9, 35.4
65 years 28.1 21.0, 36.2
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marked winter-time increase in hospital admissions for re-
spiratory infections may drive the strong seasonality of nor-
ovirus outbreaks in this setting, and that there are distinct
norovirus strains circulating in hospital populations and in
the community that may have different transmission char-
acteristics (29); therefore, the incidence of community
disease or general practitioner consultations would not nec-
essarily show the marked seasonality seen in health care-
associated outbreaks. However, detailed characterization of
the molecular epidemiology of norovirus infections in the
community is needed, for comparison with the extensive
data that already exist for hospital-acquired infections (30,
31), to understand better the factors driving the different
seasonality of health-care outbreaks and community dis-
ease. Finally, it is also possible that there was more out-
of-season norovirus transmission during this study because
of the emergence of a new norovirus variant, as described
above (32).
We have demonstrated, for the first time, how viral load
measurements can be used to make improved estimates of
norovirus disease burden. This approach is preferable to
including all IID cases who are RT-PCR positive, regard-
less of their viral load, because many may be shedding
norovirus at low concentrations, with disease caused by
another pathogen. With the widespread use of RT-PCR
for norovirus diagnosis in community-based studies, we
recommend using a real-time platform to allow consider-
ation of viral load when calculating norovirus incidence;
we have shown that additional real-time testing in a subset
of norovirus-infected IID cases would be sufficient to use
this approach, providing the subset is of a reasonable size
and is representative. Further work is needed to validate the
use of a cycle threshold value cutoff for use in studies
without a control group. Asymptomatic norovirus infection
is very common (1, 16, 21, 33–35). Therefore, this quan-
titative approach provides the most rigorous estimate of
norovirus disease burden.
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